All Stories

  1. Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus
  2. An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots
  3. NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR
  4. NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains
  5. Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase R
  6. Chronic hepatitis C infection–induced liver fibrogenesis is associated with M2 macrophage activation
  7. MAVS-dependent host species range and pathogenicity of human hepatitis A virus
  8. Mechanism of Action of Direct-Acting Antivirals: New Insights into the HCV Life Cycle
  9. How do persistent infections with hepatitis C virus cause liver cancer?
  10. Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production
  11. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle
  12. miR-122 Stimulates Hepatitis C Virus RNA Synthesis by Altering the Balance of Viral RNAs Engaged in Replication versus Translation
  13. Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors
  14. Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation
  15. Mechanisms of hepatocarcinogenesis in chronic hepatitis C
  16. HEP DART 2013: frontiers in drug development for viral hepatitis. Big Island, Hawaii, USA - December 8-12, 2013
  17. Class A Scavenger Receptor 1 (MSR1) Restricts Hepatitis C Virus Replication by Mediating Toll-like Receptor 3 Recognition of Viral RNAs Produced in Neighboring Cells
  18. Liver Injury and Disease Pathogenesis in Chronic Hepatitis C
  19. Competing and noncompeting activities of miR-122 and the 5′ exonuclease Xrn1 in regulation of hepatitis C virus replication
  20. Is Hepatitis C Virus Carcinogenic?
  21. Model Systems for Hepatitis C Research: The Cup Half Empty?
  22. Hepatitis C Virus Infection Causes Cell Cycle Arrest at the Level of Initiation of Mitosis
  23. Protease Inhibitor–Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus
  24. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer
  25. Roles of the respiratory syncytial virus trailer region: Effects of mutations on genome production and stress granule formation
  26. Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion
  27. Epigenetic Effects of Persistent Hepatitis C Virus Infection and Hepatocellular Carcinoma
  28. Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein
  29. Impaired Replication of Hepatitis C Virus Containing Mutations in a Conserved NS5B Retinoblastoma Protein-Binding Motif
  30. Tumor Suppressors, Chromosomal Instability, and Hepatitis C Virus–Associated Liver Cancer
  31. Hepatitis C Virus Induces E6AP-Dependent Degradation of the Retinoblastoma Protein
  32. Unravelling the complexities of respiratory syncytial virus RNA synthesis
  33. An intact RBR-binding motif is not required for infectivity of Maize streak virus in cereals, but is required for invasion of mesophyll cells
  34. A three-nucleotide mutation altering the Maize streak virus Rep pRBR-interaction motif reduces symptom severity in maize and partially reverts at high frequency without restoring pRBR-Rep binding
  35. Identification of Internal Sequences in the 3′ Leader Region of Human Respiratory Syncytial Virus That Enhance Transcription and Confer Replication Processivity